SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-Oct-24 4:15 PM View: | MetLife, Inc. (MET) | 01-Oct-24 | Grant | 535 | $81.78 | $43,752.30 | 3% 19.46K to 20.0K | |
12-Sep-24 4:32 PM View: | MetLife, Inc. (MET) | 10-Sep-24 | Grant | 141 | $74.63 | $10,522.80 | < 1% 19.32K to 19.46K | (10%) |
20-Jun-24 4:38 PM View: | MetLife, Inc. (MET) | 18-Jun-24 | Grant | 627 | $69.86 | $43,802.20 | 3% 18.7K to 19.32K | (3%) |
13-Jun-24 4:20 PM View: | MetLife, Inc. (MET) | 11-Jun-24 | Grant | 146 | $69.06 | $10,082.80 | < 1% 18.55K to 18.7K | (2%) |
31-May-24 8:56 PM View: | Agilon Health, Inc. (AGL) | 29-May-24 | Grant | 32,119 | -- | -- | 479% 6.7K to 38.82K | |
03-May-24 4:18 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-May-24 | Grant | 1,001 | -- | -- | 36% 2.81K to 3.81K | |
03-May-24 4:18 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-May-24 | Disposition | 1,168 | -- | -- | (31%) 3.81K to 2.64K | |
03-Apr-24 4:20 PM View: | MetLife, Inc. (MET) | 01-Apr-24 | Grant | 594 | $73.69 | $43,771.90 | 3% 17.96K to 18.55K | (8%) |
18-Mar-24 4:48 PM View: | MetLife, Inc. (MET) | 14-Mar-24 | Grant | 129 | $71.90 | $9,275.10 | < 1% 17.83K to 17.96K | (6%) |
04-Jan-24 4:40 PM View: | MetLife, Inc. (MET) | 02-Jan-24 | Grant | 650 | $67.35 | $43,777.50 | 4% 17.18K to 17.83K | < 1% |
18-Dec-23 5:19 PM View: | MetLife, Inc. (MET) | 14-Dec-23 | Grant | 132 | $66.90 | $8,830.80 | < 1% 17.05K to 17.18K | < 1% |
04-Oct-23 4:36 PM View: | MetLife, Inc. (MET) | 02-Oct-23 | Grant | 710 | $61.69 | $43,799.90 | 4% 16.34K to 17.05K | |
18-Sep-23 4:29 PM View: | MetLife, Inc. (MET) | 14-Sep-23 | Grant | 128 | $65.93 | $8,439.04 | < 1% 16.21K to 16.34K | 2% |
22-Jun-23 4:17 PM View: | MetLife, Inc. (MET) | 20-Jun-23 | Grant | 803 | $54.52 | $43,779.60 | 5% 15.4K to 16.21K | |
16-Jun-23 4:16 PM View: | MetLife, Inc. (MET) | 14-Jun-23 | Grant | 147 | $53.94 | $7,929.18 | < 1% 15.26K to 15.4K | |
03-May-23 5:01 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-May-23 | Grant | 1,168 | -- | -- | 38% 3.09K to 4.26K | |
03-May-23 5:01 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-May-23 | Disposition | 1,449 | -- | -- | (34%) 4.26K to 2.81K | |
18-Apr-23 4:48 PM View: | Agilon Health, Inc. (AGL) | 14-Apr-23 | Grant | 5,622 | -- | -- | 522% 1.08K to 6.7K | |
05-Apr-23 5:04 PM View: | MetLife, Inc. (MET) | 03-Apr-23 | Grant | 755 | $57.97 | $43,767.40 | 5% 14.5K to 15.26K | |
16-Mar-23 10:00 PM View: | MetLife, Inc. (MET) | 14-Mar-23 | Grant | 121 | $59.07 | $7,147.47 | < 1% 14.38K to 14.5K | |
02-Mar-23 7:03 PM View: | MetLife, Inc. (MET) | 28-Feb-23 | Grant | 31 | $71.73 | $2,223.63 | < 1% 14.35K to 14.38K | (6%) |
22-Feb-23 5:20 PM View: | Agilon Health, Inc. (AGL) | 17-Feb-23 | Grant | 1,078 | -- | -- | 100% 0 to 1.08K | |
05-Jan-23 4:27 PM View: | MetLife, Inc. (MET) | 03-Jan-23 | Grant | 520 | $72.15 | $37,518.00 | 4% 13.83K to 14.35K | (6%) |
16-Dec-22 4:25 PM View: | MetLife, Inc. (MET) | 14-Dec-22 | Grant | 94 | $72.84 | $6,846.96 | < 1% 13.74K to 13.83K | (7%) |
05-Oct-22 4:28 PM View: | MetLife, Inc. (MET) | 03-Oct-22 | Grant | 599 | $62.62 | $37,509.40 | 5% 13.14K to 13.73K | |
05-Oct-22 4:31 PM View: | Change Healthcare Inc. (CHNG) | 03-Oct-22 | Disposition | 40,706 | -- | -- | (100%) 40.71K to 0 | |
16-Sep-22 4:26 PM View: | MetLife, Inc. (MET) | 14-Sep-22 | Grant | 98 | $66.41 | $6,508.18 | < 1% 13.04K to 13.14K | 2% |
23-Jun-22 4:14 PM View: | MetLife, Inc. (MET) | 21-Jun-22 | Grant | 600 | $62.53 | $37,518.00 | 5% 12.44K to 13.04K | |
16-Jun-22 4:29 PM View: | MetLife, Inc. (MET) | 14-Jun-22 | Grant | 100 | $61.86 | $6,186.00 | < 1% 12.34K to 12.44K | |
03-May-22 4:48 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-May-22 | Grant | 1,449 | -- | -- | 42% 3.48K to 4.93K | |
03-May-22 4:48 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-May-22 | Disposition | 1,842 | -- | -- | (37%) 4.93K to 3.09K | |
27-Apr-22 5:07 PM View: | Change Healthcare Inc. (CHNG) | 25-Apr-22 | Grant | 7,658 | -- | -- | 23% 33.05K to 40.71K | |
05-Apr-22 4:09 PM View: | MetLife, Inc. (MET) | 01-Apr-22 | Grant | 532 | $70.50 | $37,506.00 | 5% 11.81K to 12.34K | (4%) |
16-Mar-22 4:37 PM View: | MetLife, Inc. (MET) | 14-Mar-22 | Grant | 87 | $64.69 | $5,628.03 | < 1% 11.72K to 11.81K | 4% |
05-Jan-22 4:38 PM View: | MetLife, Inc. (MET) | 03-Jan-22 | Grant | 594 | $63.23 | $37,558.60 | 5% 11.13K to 11.72K | 3% |
16-Dec-21 4:33 PM View: | MetLife, Inc. (MET) | 14-Dec-21 | Grant | 87 | $60.80 | $5,289.60 | < 1% 11.04K to 11.13K | < 1% |
05-Oct-21 4:29 PM View: | MetLife, Inc. (MET) | 01-Oct-21 | Grant | 600 | $62.52 | $37,512.00 | 6% 10.44K to 11.04K | (< 1%) |
16-Sep-21 4:39 PM View: | MetLife, Inc. (MET) | 14-Sep-21 | Grant | 82 | $60.78 | $4,983.96 | < 1% 10.36K to 10.44K | 2% |
24-Jun-21 2:26 PM View: | Change Healthcare Inc. (CHNG) | 22-Jun-21 | Grant | 7,136 | -- | -- | 28% 25.91K to 33.05K | |
17-Jun-21 5:19 PM View: | MetLife, Inc. (MET) | 15-Jun-21 | Grant | 589 | $63.77 | $37,560.50 | 6% 9.77K to 10.36K | (< 1%) |
16-Jun-21 8:58 PM View: | MetLife, Inc. (MET) | 14-Jun-21 | Grant | 73 | $63.31 | $4,621.63 | < 1% 9.7K to 9.77K | < 1% |
04-May-21 4:18 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-May-21 | Grant | 1,842 | -- | -- | 112% 1.64K to 3.48K | |
05-Apr-21 4:58 PM View: | MetLife, Inc. (MET) | 01-Apr-21 | Grant | 609 | $61.60 | $37,514.40 | 7% 9.09K to 9.7K | < 1% |
17-Mar-21 4:59 PM View: | MetLife, Inc. (MET) | 15-Mar-21 | Grant | 69 | $60.54 | $4,177.26 | < 1% 9.02K to 9.09K | (2%) |
05-Jan-21 4:32 PM View: | MetLife, Inc. (MET) | 04-Jan-21 | Grant | 814 | $46.08 | $37,509.10 | 10% 8.2K to 9.02K | 0% |
16-Dec-20 5:07 PM View: | MetLife, Inc. (MET) | 14-Dec-20 | Grant | 81 | $45.84 | $3,713.04 | < 1% 8.12K to 8.2K | 1% |
05-Oct-20 5:40 PM View: | MetLife, Inc. (MET) | 01-Oct-20 | Grant | 1,007 | $37.26 | $37,520.80 | 14% 7.11K to 8.12K | 23% |
16-Sep-20 4:25 PM View: | MetLife, Inc. (MET) | 14-Sep-20 | Grant | 83 | $38.84 | $3,223.72 | 1% 7.03K to 7.11K | 18% |
19-Jun-20 4:41 PM View: | Change Healthcare Inc. (CHNG) | 17-Jun-20 | Grant | 14,486 | -- | -- | 127% 11.43K to 25.91K | |
18-Jun-20 4:52 PM View: | MetLife, Inc. (MET) | 16-Jun-20 | Grant | 970 | $38.69 | $37,529.30 | 16% 6.06K to 7.03K | 17% |